MicroRNA and senescence: the senectome, integration and distributed control

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Cellular senescence is increasingly recognized as a crucial response to stress, particularly in cancer therapy.
• Identifying reliable biomarkers for senescence in vivo is essential for developing senescence-targeted cancer treatments.
• The complex regulatory networks of senescence, including the role of microRNAs, are not fully understood.

Purpose of the Study:

• To investigate the intricate interactions within the cellular senescence network (senectome).
• To explore the role of senescence-associated microRNAs (SA-miRNAs) as regulators of the senectome.
• To evaluate the potential of SA-miRNAs as clinical biomarkers for advancing senescence-based cancer therapies.

Main Methods:

• Analysis of complex interactions among various cellular processes involved in senescence.
• Examination of senescence-associated microRNAs (SA-miRNAs) as regulatory elements.
• Assessment of SA-miRNAs for their utility as clinical biomarkers.

Main Results:

• Senescence involves a complex interplay of cellular processes, including DNA damage, chromatin modification, and inflammatory signaling.
• MicroRNAs (miRNAs) play a significant role in regulating and inducing cellular senescence.
• SA-miRNAs are identified as potential distributed controllers of senectome regulation.

Conclusions:

• Cellular senescence is a promising target in cancer therapy, necessitating robust in vivo assessment methods.
• SA-miRNAs represent a novel class of regulators within the senescence network.
• SA-miRNAs hold potential as clinical biomarkers to facilitate the development of new senescence therapeutics.